Senior Clinical Scientist

The Cytogenetics and Molecular Haematology Department is part of the Specialist Integrated Haematological Malignancy Diagnostic service (SIHMDS) and staff work closely with other scientists in Pathology particularly Immunophenotyping and Cellular Pathology as well as research staff at Queen Mary, University of London and clinical colleagues across the region. The department provides a comprehensive cancer genomics service to East London and Essex and works in partnership with the North Thames Genomic Laboratory Hub. Services offered include Next-generation sequencing, mutation analysis via PCR, post-transplant monitoring and minimal residual disease monitoring.

The East & South East London NHS Pathology Partnership (Pathology Partnership) is being created to form a network across three NHS Trusts: Barts Health (the host), Homerton University Hospital NHS Foundation Trust and Lewisham and Greenwich NHS Trust. The Pathology Partnership will be based on well-established models for pathology networks, with the Royal London Hospital becoming the main hub laboratory for the network and Essential Service Laboratories (ESL) as a minimum at all other Hospital sites., Partnership were c. £121m per annum with a workforce establishment of circa. 860 WTE.We strive to live by our WeCare values and are committed to promoting inclusion, where every staff member has a sense of belonging. We value our differences and fully advocate, cultivate and support an inclusive working environment.We particularly welcome applications from Black, Asian and minority ethnic candidates as they are underrepresented within the Pathology Partnership and Barts Health at this band

Applications are invited from exceptional, self-motivated HCPC-registered Clinical Scientists (cancer genomics, molecular) to join the Cytogenetics and Molecular Haematology Department.

The NHS East and South East London Pathology Partnership is an arms-length organisation providing pathology services to Barts Health NHS Trust, Homerton Healthcare NHS Foundation Trust and Lewisham and Greenwich NHS Trust. The Pathology Partnership is hosted by Barts Health.The Pathology Partnership was formed in May 2021. Between 2021 and 2024 the Partnership undertook a complex transformation programme to establish a single network of laboratories, underpinned by a single Laboratory Information Management System (LIMS) and single Quality Management System (QMS).The Partnership has a main hub laboratory at the Royal London Hospital and Essential Service Laboratories (ESL) as a minimum at the six other hospital sites served by the Partnership.The Partnership has three operational divisions:o Blood Sciences including Haematology, Blood Transfusion and Biochemistryo Microbiology and Virologyo Cellular Pathology and Cancer DiagnosticsThe 2024/25 total operating costs across the